Sample management in the drug discovery space continues to evolve with the introduction of both non-small molecule modalities and new screening technologies . This session will provide case studies and outline best practices for tackling these new sample types and enabling downstream processes.
The following topics maybe covered in this session: • Cell and gene therapy • Biologics and peptides • Automation and informatics challenges • Workflow optimization • Repurposing existing tools/processes
